Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...
2h
Machine learning and cell imaging combine to predict effectiveness of multiple sclerosis medication
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...
The Hearty Soul on MSN
Study Points to Two Bacteria as Possible Causes of Multiple Sclerosis
Until now, Multiple Sclerosis has been a disease that has baffled scientists and doctors. New research, however, is pointing to a surprising potential cause of Multiple Sclerosis (MS): two specific ...
Everyday Health on MSN
Very Long Term Consequences of Steroid Use for MS
The blogger Trevis Gleason explores long-term effects of corticosteroid use in managing multiple sclerosis, and what everyone with MS should know.
A New York woman is accused of using fentanyl-laced drugs to incapacitate and then rob four men of cash, phones, sneakers and ...
The Lancet review synthesises evidence on anti beta amyloid monoclonal antibodies and the wider Alzheimer’s care pathway, ...
A major UK study has revealed that the early warning signs of multiple sclerosis (MS)—including pain, mood changes, and ...
In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.
MS primarily affects young adults and is more common in women. The prevalence continues to rise globally, including in aging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback